<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20251027067790N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-11-28</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>Effects of core stability exercises on neck pain.</public_title>
      <acronym></acronym>
      <scientific_title>Effects of adding core stability exercises to neck stability exercises and Mulligan's spinal mobilization technique on pain, range of motion and neck disability index in patients with chronic non-specific neck pain.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-11-10</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>22</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/87227</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Participants will be allocated to the intervention and control groups using a block randomization method with balanced blocks of four and a 1:1 allocation ratio. The random sequence will be generated using Random Allocation Software. The person responsible for generating the random sequence will not be involved in any stage of intervention delivery, participant assessment, or data analysis. After confirming participants’ eligibility based on inclusion and exclusion criteria, each set of four participants will form a block, and the software will randomly assign two participants to the intervention group and two to the control group, ensuring balance and randomness throughout the study. To maintain allocation concealment, each participant’s random code will be placed in identical, sealed envelopes. These envelopes will be opened in order of participant enrollment by a person not involved in the intervention process, revealing each participant’s group assignment, Blinding description: This study will use a double-blind design, meaning that both the participants and the assessor will be unaware of the type of intervention each participant receives (treatment or control group). The intervention will be delivered by a therapist different from the assessor, who will measure the outcomes only before and after the intervention, without access to group allocation.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Chronic Non-Specific Neck Pain.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: This group receives cervical stabilization exercises, Mulligan mobilization (SNAGs) and core stabilization exercises. this intervention is performed 3 sessions per week for 8 weeks, totaling 24 sessions. Intervention 2: Control group: This group receives cervical stabilization exercises and Mulligan mobilization (SNAGs). this intervention is performed 3 sessions per week for 8 weeks, totaling 24 sessions.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Some data, such as the mean age and study-related outcome information, can be shared.

When:
The access period begin 6 months after publication of the results.

To whom:
The data will be available to researchers affiliated with academic and scientific instititions.

Conditions:
The data are only permitted for scientific research analyses, not for commercial or promotional purposes. Analyses must comply with research ethics and maintain data confidentiality. Requests must be submitted formally, along with a research proposal and ethics approval. Data will only be made available after review and approval by the principal research team.

Where to obtain:
Fatemeh Razmkhah
fatemeh.razmkhah76@gmail.com

How to obtain:
Requestors must submit a formal research proposal along with their ethics approval to the principal research team. After review and approval of the proposal, the de-identified data will be provided in an appropriate format. The review and data delivery process typically takes approximately 4–6 weeks.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Fatemeh Razmkhah</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 23, Khayambashi Alley, North Nabard Street, Piroozi Street, Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1766633894</zip>
        <telephone>+98 21 3305 3591</telephone>
        <email>fatemeh.razmkhah76@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Fatemeh Razmkhah</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 23, Khayambashi Alley, North Nabard Street, Piroozi Street, Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1766633894</zip>
        <telephone>+98 21 3305 3591</telephone>
        <email>fatemeh.razmkhah76@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Pain intensity should be at least 4 out of 10
The Neck Disability Index score should be at least out of 50
Neck pain that has persisted for at least 3 months, either continuously or recurrently.
Non-specific neck pain (pain in the neck region without a pathological cause, with or without radiation to the arm)
The ratio of trunk flexor endurance Test to trunk extensor endurance Test is less than 0/5 or greater than 1/5
Men and women aged between 20 and 55 years</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>55 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Having a specific cause for neck pain
Signs of infection
Inflammatory disorder
Tumor
Osteoporosis
Fracture or traumatic injury
Disk herniation medically diagnosed as requiring surgical intervention.
Pregnancy
People who had neck surgery within the last 6 months
Use of medications affecting pain, inflammation, or musculoskeletal function—such as NSAIDs, analgesics, muscle relaxants, corticosteroids, or antidepressants—within the week prior to the study.
History of lumbar spine surgery, such as discectomy or laminectomy.
History of dizziness before enrollment and during the study period.
Uncontrolled blood pressure before enrollment and during the study period.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: This group receives cervical stabilization exercises, Mulligan mobilization (SNAGs) and core stabilization exercises. this intervention is performed 3 sessions per week for 8 weeks, totaling 24 sessions.</i_keyword>
      <i_keyword>Control group: This group receives cervical stabilization exercises and Mulligan mobilization (SNAGs). this intervention is performed 3 sessions per week for 8 weeks, totaling 24 sessions.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain intensity: Chronic non-specific neck pain, with or without radiation to the arms, lasting at least three months, will be assessed. Timepoint: Pain intensity will be measured at three time points: before the intervention, after the completion of the intervention (after 24 treatment sessions), and one month post-intervention. Method of measurement: The Visual Analog Scale (VAS) will be used to evaluate the average pain experienced by participants during the past week. This tool consists of a 10-centimeter horizontal line, with one end representing no pain (score 0) and the other end representing the worst imaginable pain (score 10). Participants will be asked to indicate their pain over the past week by marking a point on the line. The distance from the beginning of the line to the mark will be measured in millimeters, and the final pain intensity score will be reported as a number between 0 and 10.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Functional disability. Timepoint: Functional disability will be measured at three time points: before the intervention, after the completion of the intervention (after 24 treatment sessions), and one month post-intervention. Method of measurement: In this study, the Persian version of the Neck Disability Index (NDI) questionnaire, scored from 0 (no disability) to 50 (severe disability) is used to assess the level of neck disability.</sec_outcome>
      <sec_outcome>Cervical range of motion. Timepoint: Cervical range of motion will be measured at three time points: before the intervention, after the completion of the intervention (after 24 treatment sessions), and one month post-intervention. Method of measurement: In this study cervical range of motion is measured using a standard goniometer in the direction of flexion, extension, rotation and lateral bending.</sec_outcome>
      <sec_outcome>Dynamic balance (Y-Balance Test). Timepoint: Dynamic Balance will be measured at three time points: before the intervention, after the completion of the intervention (after 24 treatment sessions), and one month post-intervention. Method of measurement: In this study, dynamic balance is assessed using the Y-Balance Test in the anterior, posteromedial, and posterolateral directions. The distances reached by the participant’s reaching leg in these directions are measured by the examiner using a measuring tape.</sec_outcome>
      <sec_outcome>Patient global impression of change (PGIC). Timepoint: Patient global impression of change will be measured at two time points: after the completion of the intervention (after 24 treatment sessions), and one month post-intervention. Method of measurement: In this study, the patient’s global impression of change after treatment is evaluated using the Patient Global Impression of Change (PGIC) scale. This instrument is a 7-point scale that asks the patient to subjectively rate the overall changes in their condition compared to the beginning of treatment. The response options range from “very much worse” to “very much improved.” Higher scores indicate greater patient satisfaction with the treatment outcome.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-10-14</approval_date>
        <contact_name>ethics committee of tehran university of medical sciences</contact_name>
        <contact_address>School of Rehabilitation, Tehran University of Medical Sciences, corner of Safialishah Street, Enqelab Street, Tehran, Iran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
